Evonik signed a purchase agreement on July 4, 2016, for acquisition of the probiotics business of the Spanish company NOREL.
The agreement sees Evonik acquiring NOREL’s probiotics product portfolio as well as the company’s site in Leon (Spain). The business will be integrated into Evonik’s Animal Nutrition Business Line.
Evonik is currently expanding its portfolio of sustainable and healthy solutions in the field of animal nutrition and striving to provide innovative solutions for antibiotic-free livestock management.
“For us, this acquisition marks an important step into the probiotics market. By combining the technologies of NOREL and Evonik we can create a platform for the development of new customer solutions, which are built around probiotics product families and application services,” says Dr. Emmanuel Auer, head of the Animal Nutrition Business Line of Evonik.
NOREL’s probiotics business gives Evonik access to this product range and to more than 20 markets including the European market.